Allfrey V, Faulkner RM,Mirsky AE (1964) Acetylation and methylation ofhistones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci USA 51:786-794 Bachman KE, Park BH, Rhee I, Rajagopalan H, Herman JG, Baylin SB, Kinzler KW, Vogelstein B (2003) Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 3:89-95

Ballestar E, Paz MF,Valle L, Wei S, Fraga MF, Espada, J, Cigudosa JC, Huang TH-M, Esteller M (2003) Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J 22:1-11 Bestor TH, Laudano A, Mattaliano R, Ingram V (1988) Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzyme is related to bacterial restriction methyltransferases. J Mol Biol 203:971-983

Bird A (1992) The essentials of DNA methylation. Cell 70:5-8 Cedar H (1988) DNA methylation and gene activity. Cell 53:3-4

Chen T, Ueda Y, Dodge JE, Wang Z, Li E (2003) Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b. Mol Cell Biol 23:5594-5605

Costello JF, Smiraglia DJ, Plass C (2002) Restriction landmark genome scanning. Methods 27:144-149

Daniel JM, Reynolds AB (1999) The catenin p120(ctn) interacts with Kaiso, a novel

BTB/POZ domain zinc finger transcription factor. Mol Cell Biol 19:3614-3623 Deng G,Chen A,Pong E,Kim YS (2001) Methylation in hMLH1 promoter interferes with its binding to transcription factor CBF and inhibits gene expression. Oncogene 20:7120-7127

Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M, Fuks F, Lo Coco F, Kouzarides T, Nervi C, Minucci S, Pelicci PG (2002) Methyltransferase recruitment and DNA hyper-methylation of target promoters by an oncogenic transcription factor. Science 295:1079-1082

Esteller M (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21:5427-5440 Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229 Esteller M, Fraga MF, Paz MF, Campo E, Colomer D, Novo FJ, Calasanz MJ, Galm O, Guo M, Benitez J, Herman JG (2002) Cancer epigenetics and methylation. Science 297:1807-1808 Fujita N, Watanabe S, Ichimura T, Tsuruzoe S, Shinkai Y, Tachibana M, Chiba T, Nakao M (2003) Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 hete-rochromatic complex for DNA methylation-based transcriptional repression. J Biol Chem 278:24132-24138 Fuks F,Burgers WA,Godin N,Kasai M,Kouzarides T (2001) Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J 20:2536-2544

Fuks F, Hurd PJ, Deplus R, Kouzarides T (2003a) The DNA methyltransferases associate with

HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res 31:2305-2312 Fuks F, Hurd PJ, Wolf D, Nan X, Bird AP, Kouzarides T (2003b) The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 278:4035-4040

Hendrich B, Bird AP (1998) Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 18:6538-6547 Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM, Baylin SB (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91:9700-9704 Hermann A, Schmitt S,Jeltsch A (2003) The human Dnmt2 has residual DNA-(cytosine-C5)

methyltransferase activity. J Biol Chem 278:31717-31721 Jamieson AC, Miller JC, Pabo CO (2003) Drug discovery with engineered zinc-finger proteins. Nat Rev Drug Discov 2:361-368

Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19:187-191 Kass SU, Pruss D, Wolffe AP (1997) How does DNA methylation repress transcription?

Trends Genet 13:444-449 Keshet I, Lieman-Hurwitz J, Cedar H (1986) DNA methylation affects the formation of active chromatin. Cell 44:535-545 Kim GD, Ni J, Kelesoglu N, Roberts RJ, Pradhan S (2002) Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J 21:4183-4195

Lee JH, Skalnik DG (2002) CpG-binding protein is a nuclear matrix- and euchromatin-asso-ciated protein localized to nuclear speckles containing human trithorax. Identification of nuclear matrix targeting signals. J Biol Chem 277:42259-42267 Lee JH,Voo KS, Skalnik DG (2001) Identification and characterization of the DNA binding domain of CpG-binding protein. J Biol Chem 276:44669-44676 Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, Bird A (1992) Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69:905-914 Magdinier F, Wolffe AP (2001) Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc Natl Acad Sci USA 98:4990-4995

Meehan RR, Lewis JD, Bird AP (1992) Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res 20:5085-5092 Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386-389 Ng HH, Zhang Y, Hendrich B, Johnson CA, Turner BM, Erdjument-Bromage H, Tempst P, Reinberg D, Bird A (1999) MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet 23:58-61 Ng HH, Jeppesen P, Bird A (2000) Active repression of methylated genes by the chromosomal protein MBD1.Mol Cell Biol 20:1394-1406 Nguyen CT, Gonzales FA, Jones PA (2001) Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methyla-tion, MeCP2 binding and acetylation. Nucleic Acids Res 29:4598-4606 Okano M, Xie S, Li E (1998) Cloning and characterization of a family of novel mammalian

DNA (cytosine-5) methyltransferases. Nat Genet 19:219-220 Okano M,Bell DW,Haber DA,Li E (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99:247-257 Paz MF, Fraga MF, Avila S, Guo M, Pollan M, Herman JG, Esteller M (2003a) A systematic profile of DNA methylation in human cancer cell lines. Cancer Res 63:1114-1121 Paz MF, Wei S, Cigudosa JC, Rodriguez-Perales S, Peinado MA, Huang TH, Esteller M (2003b) Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases. Hum Mol Genet 12:2209-2219 Prokhortchouk A, Hendrich B, Jorgensen H, Ruzov A, Wilm M, Georgiev G, Bird A, Prokhortchouk E (2001) The p120 catenin partner Kaiso is a DNA methylation-depen-dent transcriptional repressor. Genes Dev 15:1613-1618 Rhee I, Jair KW, Yen RW, Lengauer C, Herman JG, Kinzler KW, Vogelstein B, Baylin SB, Schuebel KE (2000) CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404:1003-1007 Robertson KD,Ait-Si-Ali S,Yokochi T,Wade PA, Jones PL,Wolffe AP (2000) DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 25:338-342

Snowden AW, Zhang L, Urnov F, Dent C, Jouvenot Y, Zhong X, Rebar EJ, Jamieson AC, Zhang HS, Tan S, Case CC, Pabo CO, Wolffe AP, Gregory PD (2003) Repression of vascular endothelial growth factor A in glioblastoma cells using engineered zinc finger transcription factors. Cancer Res 63:8968-8976 Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403:4145

Suzuki H, Gabrielson E, Chen W, Anbazhagan R,van Engeland M,Weijenberg MP, Herman JG, Baylin SB (2002) A genomic screen for genes upregulated by demethylation and his-tone deacetylase inhibition in human colorectal cancer. Nat Genet 31:141-149 Tate PH, Bird AP (1993) Effects of DNA methylation on DNA-binding proteins and gene expression. Curr Opin Genet Dev 3:226-231 Turner BM (2002) Cellular memory and the histone code. Cell 111:285-291 Villar-Garea A, Esteller M (2003) DNA demethylating agents and chromatin-remodelling drugs: which, how and why? Curr Drug Metab 4:11-31 Villar-Garea A, Fraga MF, Espada J, Esteller M (2003) Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells. Cancer Res 63:4984-4989 Wade PA, Gegonne A,Jones PL, Ballestar E,Aubry F,Wolffe AP (1999) Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat Genet 23:62-66

Yoder JA, Walsh CP, Bestor TH (1997) Cytosine methylation and the ecology of intrage-

nomic parasites. Trends Genet 13:335-340 Yoder JA, Bestor TH (1998) A candidate mammalian DNA methyltransferase related to pmt1p of fission yeast. Hum Mol Genet 7:279-284 Yoon HG, Chan DW, Reynolds AB, Qin J,Wong J (2003) N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol Cell 12:723-734

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment